Skip to main content
Erschienen in: Journal of Nuclear Cardiology 6/2020

19.11.2018 | Original Article

Higher incidence of vasodilator-induced left ventricular cavity dilation by PET when compared to treadmill exercise-ECHO in hypertrophic cardiomyopathy

verfasst von: Dai-Yin Lu, MD, Hulya Yalçin, MD, Sanjay Sivalokanathan, MD, Gabriela V. Greenland, MD, Nestor Vasquez, MD, Fatih Yalçin, MD, Min Zhao, MD, Ines Valenta, MD, Peter Ganz, MD, Miguel Hernandez Pampaloni, MD, PhD, Stefan Zimmerman, MD, Thomas H. Schindler, MD, Theodore P. Abraham, MD, M. Roselle Abraham, MD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Vasodilator-induced transient left ventricular cavity dilation (LVCD) by positron emission tomography (PET) is associated with microvascular dysfunction in hypertrophic cardiomyopathy (HCM). Here we assessed whether HCM patients who develop LVCD by PET during vasodilator stress also develop LV cavity dilation by echocardiography (ECHO-LVCD) following exercise stress.

Methods

A retrospective analysis of cardiac function and myocardial blood flow (MBF) was conducted in 108 HCM patients who underwent perfusion-PET and exercise-ECHO as part of their clinical evaluation. We performed a head-to-head comparison of LV volumes and ejection fraction (LVEF) at rest and stress (during vasodilator stress, post-exercise), in 108 HCM patients. A ratio > 1.13 of stress to rest LV volumes was used to define PET-LVCD, and a ratio > 1.17 of stress to rest LVESV was used to define ECHO-LVCD. Patients were divided into 2 groups based on the presence/absence of PET-LVCD. MBF and myocardial flow reserve were quantified by PET, and global longitudinal strain (GLS) was assessed by ECHO at rest/stress in the two groups.

Results

PET-LVCD was observed in 51% (n = 55) of HCM patients, but only one patient had evidence of ECHO-LVCD (ratio = 1.36)—this patient also had evidence of PET-LVCD (ratio = 1.20). The PET-LVCD group had lower PET-LVEF during vasodilator stress, but ECHO-LVEF increased in both groups post-exercise. The PET-LVCD group demonstrated higher LV mass, worse GLS at rest/stress, and lower myocardial flow reserve. Incidence of ischemic ST-T changes was higher in the PET-LVCD group during vasodilator stress (42 vs 17%), but similar (30%) in the two groups during exercise.

Conclusion

PET-LVCD reflects greater degree of myopathy and microvascular dysfunction in HCM. Differences in the cardiac effects of exercise and vasodilators and timing of stress-image acquisition could underlie discordance in ischemic EKG changes and LVCD by ECHO and PET, in HCM.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350-8.CrossRef Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350-8.CrossRef
2.
Zurück zum Zitat Yao SS, Shah A, Bangalore S, Chaudhry FA. Transient ischemic left ventricular cavity dilation is a significant predictor of severe and extensive coronary artery disease and adverse outcome in patients undergoing stress echocardiography. J Am Soc Echocardiogr 2007;20:352-8.CrossRef Yao SS, Shah A, Bangalore S, Chaudhry FA. Transient ischemic left ventricular cavity dilation is a significant predictor of severe and extensive coronary artery disease and adverse outcome in patients undergoing stress echocardiography. J Am Soc Echocardiogr 2007;20:352-8.CrossRef
3.
Zurück zum Zitat McLaughlin MG, Danias PG. Transient ischemic dilation: A powerful diagnostic and prognostic finding of stress myocardial perfusion imaging. J Nucl Cardiol 2002;9:663-7.CrossRef McLaughlin MG, Danias PG. Transient ischemic dilation: A powerful diagnostic and prognostic finding of stress myocardial perfusion imaging. J Nucl Cardiol 2002;9:663-7.CrossRef
4.
Zurück zum Zitat Cannon RO 3rd, Dilsizian V, O’Gara PT, Udelson JE, Schenke WH, Quyyumi A, et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 1991;83:1660-7.CrossRef Cannon RO 3rd, Dilsizian V, O’Gara PT, Udelson JE, Schenke WH, Quyyumi A, et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 1991;83:1660-7.CrossRef
5.
Zurück zum Zitat Bravo PE, Tahari A, Pozios I, Luo HC, Bengel FM, Wahl RL, et al. Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanisms. J Nucl Cardiol 2016;23:1304-14.CrossRef Bravo PE, Tahari A, Pozios I, Luo HC, Bengel FM, Wahl RL, et al. Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanisms. J Nucl Cardiol 2016;23:1304-14.CrossRef
6.
Zurück zum Zitat Bravo PE, Pinheiro A, Higuchi T, Rischpler C, Merrill J, Santaularia-Tomas M, et al. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy. J Nucl Med 2012;53:407-14.CrossRef Bravo PE, Pinheiro A, Higuchi T, Rischpler C, Merrill J, Santaularia-Tomas M, et al. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy. J Nucl Med 2012;53:407-14.CrossRef
7.
Zurück zum Zitat Yalcin H, Valenta I, Yalcin F, Corona-Villalobos C, Vasquez N, Ra J, et al. Effect of diffuse subendocardial hypoperfusion on left ventricular cavity size by (13)N-ammonia perfusion pet in patients with hypertrophic cardiomyopathy. Am J Cardiol 2016;118:1908-15.CrossRef Yalcin H, Valenta I, Yalcin F, Corona-Villalobos C, Vasquez N, Ra J, et al. Effect of diffuse subendocardial hypoperfusion on left ventricular cavity size by (13)N-ammonia perfusion pet in patients with hypertrophic cardiomyopathy. Am J Cardiol 2016;118:1908-15.CrossRef
8.
Zurück zum Zitat Camici PG, Olivotto I, Rimoldi OE. The coronary circulation and blood flow in left ventricular hypertrophy. J Mol Cell Cardiol 2012;52:857-64.CrossRef Camici PG, Olivotto I, Rimoldi OE. The coronary circulation and blood flow in left ventricular hypertrophy. J Mol Cell Cardiol 2012;52:857-64.CrossRef
9.
Zurück zum Zitat Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;8:545-57.CrossRef Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;8:545-57.CrossRef
10.
Zurück zum Zitat Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011;58:e212-60.CrossRef Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011;58:e212-60.CrossRef
11.
Zurück zum Zitat Luo HC, Dimaano VL, Kembro JM, Hilser A, Hurtado-de-Mendoza D, Pozios I, et al. Exercise heart rates in patients with hypertrophic cardiomyopathy. Am J Cardiol 2015;115:1144-50.CrossRef Luo HC, Dimaano VL, Kembro JM, Hilser A, Hurtado-de-Mendoza D, Pozios I, et al. Exercise heart rates in patients with hypertrophic cardiomyopathy. Am J Cardiol 2015;115:1144-50.CrossRef
12.
Zurück zum Zitat Yalcin H, Valenta I, Zhao M, Tahari A, Lu DY, Higuchi T et al. Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy. J Nucl Cardiol 2018. Yalcin H, Valenta I, Zhao M, Tahari A, Lu DY, Higuchi T et al. Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy. J Nucl Cardiol 2018.
13.
Zurück zum Zitat Choi Y, Huang SC, Hawkins RA, Kuhle WG, Dahlbom M, Hoh CK, et al. A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. J Nucl Med 1993;34:488-97.PubMed Choi Y, Huang SC, Hawkins RA, Kuhle WG, Dahlbom M, Hoh CK, et al. A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. J Nucl Med 1993;34:488-97.PubMed
14.
Zurück zum Zitat Van Tosh A, Reichek N, Palestro CJ, Nichols KJ. Effect of outflow tract contributions to 82Rb-PET global myocardial blood flow computations. J Nucl Med Technol 2016;44:78-84.CrossRef Van Tosh A, Reichek N, Palestro CJ, Nichols KJ. Effect of outflow tract contributions to 82Rb-PET global myocardial blood flow computations. J Nucl Med Technol 2016;44:78-84.CrossRef
15.
Zurück zum Zitat Rischpler C, Higuchi T, Fukushima K, Javadi MS, Merrill J, Nekolla SG, et al. Transient ischemic dilation ratio in 82Rb PET myocardial perfusion imaging: Normal values and significance as a diagnostic and prognostic marker. J Nucl Med 2012;53:723-30.CrossRef Rischpler C, Higuchi T, Fukushima K, Javadi MS, Merrill J, Nekolla SG, et al. Transient ischemic dilation ratio in 82Rb PET myocardial perfusion imaging: Normal values and significance as a diagnostic and prognostic marker. J Nucl Med 2012;53:723-30.CrossRef
16.
Zurück zum Zitat Lu DY, Hailesealassie B, Ventoulis I, Liu H, Liang HY, Nowbar A, et al. Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy. Int J Cardiol 2017;243:290-5.CrossRef Lu DY, Hailesealassie B, Ventoulis I, Liu H, Liang HY, Nowbar A, et al. Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy. Int J Cardiol 2017;243:290-5.CrossRef
17.
Zurück zum Zitat Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:e14. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:e14.
18.
Zurück zum Zitat Kataoka A, Scherrer-Crosbie M, Senior R, Garceau P, Valbuena S, Celutkiene J, et al. Transient ischemic dilatation during stress echocardiography: An additional marker of significant myocardial ischemia. Echocardiography 2016;33:1202-8.CrossRef Kataoka A, Scherrer-Crosbie M, Senior R, Garceau P, Valbuena S, Celutkiene J, et al. Transient ischemic dilatation during stress echocardiography: An additional marker of significant myocardial ischemia. Echocardiography 2016;33:1202-8.CrossRef
19.
Zurück zum Zitat Smiseth OA, Torp H, Opdahl A, Haugaa KH, Urheim S. Myocardial strain imaging: How useful is it in clinical decision making? Eur Heart J 2016;37:1196-207.CrossRef Smiseth OA, Torp H, Opdahl A, Haugaa KH, Urheim S. Myocardial strain imaging: How useful is it in clinical decision making? Eur Heart J 2016;37:1196-207.CrossRef
20.
Zurück zum Zitat Liu H, Pozios I, Haileselassie B, Nowbar A, Sorensen LL, Phillip S, et al. Role of global longitudinal strain in predicting outcomes in hypertrophic cardiomyopathy. Am J Cardiol 2017;120:670-5.CrossRef Liu H, Pozios I, Haileselassie B, Nowbar A, Sorensen LL, Phillip S, et al. Role of global longitudinal strain in predicting outcomes in hypertrophic cardiomyopathy. Am J Cardiol 2017;120:670-5.CrossRef
21.
Zurück zum Zitat Bravo PE, Zimmerman SL, Luo HC, Pozios I, Rajaram M, Pinheiro A, et al. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 2013;6:210-7.CrossRef Bravo PE, Zimmerman SL, Luo HC, Pozios I, Rajaram M, Pinheiro A, et al. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 2013;6:210-7.CrossRef
22.
Zurück zum Zitat Spiewak M, Malek LA, Misko J, Chojnowska L, Milosz B, Klopotowski M, et al. Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy. Eur J Radiol 2010;74:e149-53.CrossRef Spiewak M, Malek LA, Misko J, Chojnowska L, Milosz B, Klopotowski M, et al. Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy. Eur J Radiol 2010;74:e149-53.CrossRef
23.
Zurück zum Zitat Corona-Villalobos CP, Saha S, Pozios I, Hurtado-de-Mendoza Paz D, Sorensen L, Gonzalez Cordoba J, et al. Exercise-QTc is associated with diffuse interstitial fibrosis reflected by lower approximated T1 relaxation time in hypertrophic cardiomyopathy patients. J Electrocardiol 2017;50:484-90.CrossRef Corona-Villalobos CP, Saha S, Pozios I, Hurtado-de-Mendoza Paz D, Sorensen L, Gonzalez Cordoba J, et al. Exercise-QTc is associated with diffuse interstitial fibrosis reflected by lower approximated T1 relaxation time in hypertrophic cardiomyopathy patients. J Electrocardiol 2017;50:484-90.CrossRef
24.
Zurück zum Zitat Otasevic P, Popovic Z, Pratali L, Vlahovic A. Vasiljevic JD, Neskovic AN. Right vs. left ventricular contractile reserve in one-year prognosis of patients with idiopathic dilated cardiomyopathy: Assessment by dobutamine stress echocardiography. Eur J Echocardiogr 2005;6:429-34.CrossRef Otasevic P, Popovic Z, Pratali L, Vlahovic A. Vasiljevic JD, Neskovic AN. Right vs. left ventricular contractile reserve in one-year prognosis of patients with idiopathic dilated cardiomyopathy: Assessment by dobutamine stress echocardiography. Eur J Echocardiogr 2005;6:429-34.CrossRef
25.
Zurück zum Zitat Ray EC, Landis ME, Miller VM. Effects of dietary L-arginine on the reactivity of canine coronary arteries. Vasc Med 1999;4:211-7.CrossRef Ray EC, Landis ME, Miller VM. Effects of dietary L-arginine on the reactivity of canine coronary arteries. Vasc Med 1999;4:211-7.CrossRef
26.
Zurück zum Zitat Higginbotham MB, Morris KG, Williams RS, McHale PA, Coleman RE, Cobb FR. Regulation of stroke volume during submaximal and maximal upright exercise in normal man. Circ Res 1986;58:281-91.CrossRef Higginbotham MB, Morris KG, Williams RS, McHale PA, Coleman RE, Cobb FR. Regulation of stroke volume during submaximal and maximal upright exercise in normal man. Circ Res 1986;58:281-91.CrossRef
27.
Zurück zum Zitat Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 2008;88:1009-86.CrossRef Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 2008;88:1009-86.CrossRef
28.
Zurück zum Zitat Okeie K, Shimizu M, Yoshio H, Ino H, Yamaguchi M, Matsuyama T, et al. Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2000;36:856-63.CrossRef Okeie K, Shimizu M, Yoshio H, Ino H, Yamaguchi M, Matsuyama T, et al. Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2000;36:856-63.CrossRef
29.
Zurück zum Zitat Belardinelli L, Shryock JC, Snowdy S, Zhang Y, Monopoli A, Lozza G, et al. The A2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther 1998;284:1066-73.PubMed Belardinelli L, Shryock JC, Snowdy S, Zhang Y, Monopoli A, Lozza G, et al. The A2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther 1998;284:1066-73.PubMed
30.
Zurück zum Zitat Farhad H, Murthy VL. Pharmacologic manipulation of coronary vascular physiology for the evaluation of coronary artery disease. Pharmacol Ther 2013;140:121-32.CrossRef Farhad H, Murthy VL. Pharmacologic manipulation of coronary vascular physiology for the evaluation of coronary artery disease. Pharmacol Ther 2013;140:121-32.CrossRef
31.
Zurück zum Zitat Al Jaroudi W, Iskandrian AE. Regadenoson: A new myocardial stress agent. J Am Coll Cardiol 2009;54:1123-30.CrossRef Al Jaroudi W, Iskandrian AE. Regadenoson: A new myocardial stress agent. J Am Coll Cardiol 2009;54:1123-30.CrossRef
32.
Zurück zum Zitat Gallagher KP. Transmural steal with isoproterenol and exercise in poststenotic myocardium. Basic Res Cardiol 1990;85:145-55.PubMed Gallagher KP. Transmural steal with isoproterenol and exercise in poststenotic myocardium. Basic Res Cardiol 1990;85:145-55.PubMed
33.
Zurück zum Zitat Sciagra R, Calabretta R, Cipollini F, Passeri A, Castello A, Cecchi F, et al. Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: A (13)NH3 gated PET study. Eur J Nucl Med Mol Imaging 2017;44:866-75.CrossRef Sciagra R, Calabretta R, Cipollini F, Passeri A, Castello A, Cecchi F, et al. Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: A (13)NH3 gated PET study. Eur J Nucl Med Mol Imaging 2017;44:866-75.CrossRef
34.
Zurück zum Zitat Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, et al. Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients. Hypertens Res 2007;30:541-8.CrossRef Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, et al. Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients. Hypertens Res 2007;30:541-8.CrossRef
35.
Zurück zum Zitat McClellan JR, Travin MI, Herman SD, Baron JI, Golub RJ, Gallagher JJ, et al. Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events. Am J Cardiol 1997;79:600-5.CrossRef McClellan JR, Travin MI, Herman SD, Baron JI, Golub RJ, Gallagher JJ, et al. Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events. Am J Cardiol 1997;79:600-5.CrossRef
36.
Zurück zum Zitat Weiss AT, Berman DS, Lew AS, Nielsen J, Potkin B, Swan HJ, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: A marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752-9.CrossRef Weiss AT, Berman DS, Lew AS, Nielsen J, Potkin B, Swan HJ, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: A marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752-9.CrossRef
37.
Zurück zum Zitat Brunken RC. Why LV dilatation with vasodilator stress in hypertrophic cardiomyopathy? J Nucl Cardiol 2016;23:1315-8.CrossRef Brunken RC. Why LV dilatation with vasodilator stress in hypertrophic cardiomyopathy? J Nucl Cardiol 2016;23:1315-8.CrossRef
Metadaten
Titel
Higher incidence of vasodilator-induced left ventricular cavity dilation by PET when compared to treadmill exercise-ECHO in hypertrophic cardiomyopathy
verfasst von
Dai-Yin Lu, MD
Hulya Yalçin, MD
Sanjay Sivalokanathan, MD
Gabriela V. Greenland, MD
Nestor Vasquez, MD
Fatih Yalçin, MD
Min Zhao, MD
Ines Valenta, MD
Peter Ganz, MD
Miguel Hernandez Pampaloni, MD, PhD
Stefan Zimmerman, MD
Thomas H. Schindler, MD
Theodore P. Abraham, MD
M. Roselle Abraham, MD
Publikationsdatum
19.11.2018
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 6/2020
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-018-01521-x

Weitere Artikel der Ausgabe 6/2020

Journal of Nuclear Cardiology 6/2020 Zur Ausgabe

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.